The demonstration that a concentration of CPZ in the medium that was within clinical reach could effectively kill intracellular Mtb by non killing human macrophages [54], sparked interest in the potential that CPZ offered for therapy of tuberculosis; especially multi-drug resistant infections. The gene discussed is CPZ; the disease is tuberculosis.